1-4 of 4
Christine Mayr, MD
Close
Sort by
Journal Articles

Deregulation of miRNAs by Epigenetic Silencing Disrupts Suppression of the Oncogene PLAG1 in Chronic Lymphocytic Leukemia.

Christian P Pallasch, MD, Michaela Patz, PhD, Yoon Jung Park, PhD, Susanne Hagist, MD, Daniela Eggle, PhD, Rainer Claus, MD, Svenja Debey-Pascher, PhD, Alexandra Schulz, Lukas P Frenzel, MD, Julia Claasen, Nadine Kutsch, Günter Krause, PhD, Christine Mayr, MD, Andreas Rosenwald, MD, Christoph Plass, PhD, Joachim L Schultze, MD, Michael Hallek, MD, Clemens-Martin Wendtner, MD
Journal: Blood
Blood (2009) 114 (22): 3463.
https://doi.org/10.1182/blood.V114.22.3463.3463
Published: 2009
Journal Articles

Occurrence of Chromosomal Translocations as Independent Prognostic Factor in Chronic Lymphocytic Leukemia.

Christine Mayr, MD, Cathrine Schulz, M.D., Stephan Stilgenbauer, M.D., Alexander Kröber, M.D., Hartmut Döhner, M.D., Ulrich Jäger, M.D., Birgit Kainz, M.D., Georg Hopfinger, M.D., Rüdiger Hoffmann, M.D., Clemens Wendtner, M.D., Michael Hallek, M.D., Michael R. Speicher, M.D.
Journal: Blood
Blood (2006) 108 (11): 2084.
https://doi.org/10.1182/blood.V108.11.2084.2084
Published: 2006
Journal Articles

High Incidence of Translocations in CLL: A New Prognostic Marker for Infavorable Survival Outcome.

Christine Mayr, MD, David M. Kofler, MD, Raymund Buhmann, MD, John Strehl, MD, Raymonde Busch, Michael Hallek, MD, Clemens-Martin Wendtner, MD
Journal: Blood
Blood (2004) 104 (11): 17.
https://doi.org/10.1182/blood.V104.11.17.17
Published: 2004
Journal Articles

Fibromodulin as a Novel Tumor-Associated Antigen (TAA) in Chronic Lymphocytic Leukemia (CLL) Which Allows Expansion of Specific CD8+ Autologous T Lymphocytes.

Christine Mayr, MD, Dagmar Bund, Martin Schlee, PhD, Andreas Moosmann, PhD, Michael Hallek, MD, Clemens Wendtner, MD
Journal: Blood
Blood (2004) 104 (11): 175.
https://doi.org/10.1182/blood.V104.11.175.175
Published: 2004